![Albert C. Cefalo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Albert C. Cefalo
Profile
Albert C.
Cefalo held the position of Vice President-Compliance & Regulatory Affairs at Analogic Corp.
and the position of SVP-Quality Assurance & Regulatory Affairs at Breas Medical AB.
He obtained an undergraduate degree from Franklin Pierce University.
Former positions of Albert C. Cefalo
Companies | Position | End |
---|---|---|
Breas Medical AB
![]() Breas Medical AB Medical SpecialtiesHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breas Medical AB is a Swedish company that manufactures home respiratory ventilators and sleep apnea products. The company is based in Mölnlycke, Sweden. Breas Medical was acquired by Human Design Medical LLC, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from General Electric Co. on February 04, 2014. | General Counsel | - |
ANALOGIC CORPORATION | Compliance Officer | - |
Training of Albert C. Cefalo
Franklin Pierce University | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
Analogic Corp.
![]() Analogic Corp. Medical SpecialtiesHealth Technology Analogic Corp. engages in the business of designing, development manufacturing, and supporting technically advanced and cost-effective imaging and detection, and power and automation solutions for security, healthcare, and other high-end industrial markets. The firm is also involved in the innovation in the field of computed tomography. The company was founded by Bernard Marshall Gordon on November 27, 1967 and is headquartered in Peabody, MA. | Health Technology |
Breas Medical AB
![]() Breas Medical AB Medical SpecialtiesHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Breas Medical AB is a Swedish company that manufactures home respiratory ventilators and sleep apnea products. The company is based in Mölnlycke, Sweden. Breas Medical was acquired by Human Design Medical LLC, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from General Electric Co. on February 04, 2014. | Health Technology |
- Stock Market
- Insiders
- Albert C. Cefalo